Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

0.4700 -0.0047 (-0.99%)
Streaming Delayed Price Updated: 10:04 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,803
Open 0.4689
Bid (Size) 0.4700 (800)
Ask (Size) 0.4850 (200)
Prev. Close 0.4747
Today's Range 0.4650 - 0.4800
52wk Range 0.4351 - 3.420
Shares Outstanding 41,084,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Announces Final Results of Tender Offer
From Anebulo Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
-58.4%
-58.4%
1 Month
-58.4%
-58.4%
3 Month
-80.2%
-80.2%
6 Month
-80.4%
-80.4%
1 Year
-68.0%
-68.0%

More News

Read More
News headline image
Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
Top movers in Friday's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
From Anebulo Pharmaceuticals, Inc.
Via Business Wire

Frequently Asked Questions

Is Anebulo Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Anebulo Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Anebulo Pharmaceuticals, Inc. - Common Stock trade on?
Anebulo Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock is ANEB on the Nasdaq Stock Market
What is the current price of Anebulo Pharmaceuticals, Inc. - Common Stock?
The current price of Anebulo Pharmaceuticals, Inc. - Common Stock is 0.4700
When was Anebulo Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Anebulo Pharmaceuticals, Inc. - Common Stock was at 02/12/26 10:04 AM ET
What is the market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock is 19.31M
How many shares of Anebulo Pharmaceuticals, Inc. - Common Stock are outstanding?
Anebulo Pharmaceuticals, Inc. - Common Stock has 19M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.